Ann: OncoSil AGM CEO Presentation, page-97

Yes, every one would agree that pancreatic cancer is an extremely difficult disease to treat. It's also important to appreciate that it's likely that pancreatic cancer is not uniformly the same disease, even though it occurs in the same organ.So some genetic types may respond better to chemotherapy and some to radiation. That was true for SIRT where some subtypes of hepatocellular carcinoma responded very well, and in others SIRT was no better than doing nothing and chemo was superior.

And its still an open question though as to whether or not Oncosil's treatment improves the outcome of pancreatic cancer. Don't assume that just because radiation can kill human cells, that it automatically can deliver better disease control in every case. Its important to follow that facts. wherever they lead. Its OK to hope that a treatment will work, but wrong to believe that it does until the facts prove it. Otherwise sound scientific judgement gets clouded by emotion, especially for investors who have laid bets on the outcome.